These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9192757)

  • 41. Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.
    Dahlbäck B
    J Lab Clin Med; 1999 May; 133(5):415-22. PubMed ID: 10235124
    [No Abstract]   [Full Text] [Related]  

  • 42. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of factor Va by activated protein C on selected human tumor cell lines.
    Nakagaki T; Sueyoshi T; Kisiel W
    Haemostasis; 1992; 22(4):165-72. PubMed ID: 1468718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor V: Dr. Jeckyll and Mr. Hyde.
    Kalafatis M; Mann KG
    Adv Exp Med Biol; 2001; 489():31-43. PubMed ID: 11554589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
    J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The binding of activated protein C to factors V and Va.
    Krishnaswamy S; Williams EB; Mann KG
    J Biol Chem; 1986 Jul; 261(21):9684-93. PubMed ID: 3755431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.
    Griffin JH; Kojima K; Banka CL; Curtiss LK; Fernández JA
    J Clin Invest; 1999 Jan; 103(2):219-27. PubMed ID: 9916134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.
    Nyberg P; Dahlbäck B; García de Frutos P
    FEBS Lett; 1998 Aug; 433(1-2):28-32. PubMed ID: 9738926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structure and function of murine factor V and its inactivation by protein C.
    Yang TL; Cui J; Rehumtulla A; Yang A; Moussalli M; Kaufman RJ; Ginsburg D
    Blood; 1998 Jun; 91(12):4593-9. PubMed ID: 9616155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
    Norstrøm E; Thorelli E; Dahlbäck B
    Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low prevalence of the factor V Leiden among patients with ischemic stroke.
    Sánchez J; Román J; de la Torre MJ; Velasco F; Torres A
    Haemostasis; 1997; 27(1):9-15. PubMed ID: 9097081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
    Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.